Parkinson's affects more than 1 million people in the US. Only 10 to 20% of people with Parkinson's experience symptoms ...

The progression of Parkinson's disease often requires a change of therapy. An expert explains when this should be done and ...

People with Parkinson’s disease are to benefit from cutting edge AI technology that allows neuroscientists to safely test medication and treatment on a ‘digital twin’ brain, thanks to a £1m funding ...

This report offers insights into recent health news, encompassing advancements in Parkinson's and cancer treatments, ...

Intra-Cellular Therapies is developing Lenrispodun for the treatment of patients with Parkinson's Disease in a phase 2 study.

22, 2024 — Researchers have discovered a network of neurons in the brain of mice that help them make right and left turns. In the future, the discovery may be used in treatment for Parkinson's ...

AbbVie (NYSE: ABBV) today announced positive topline results from its pivotal Phase 3 TEMPO-2 trial evaluating investigational tavapadon as a flexible-dose monotherapy in early Parkinson's disease.

A study from the University of Arizona shows that the protein PNA5 helps protect brain cells, offering a promising avenue for ...

The 'Sex and the City' actress said her dad Keith Eugene Davis had been living with Parkinson's disease for the last decade and praised him for the "perseverance he showed in a very real and ...

The growth is driven by the increasing prevalence of neurological disorders and the continuous advancements in treatment ...

We think UCB is in good financial health, with solid earnings and cash flow generation. UCB has deleveraged over the years, and it ended 2023 with about EUR 2.2 billion in net debt on its balance ...